project id: TCGA-LUAD; case submitter id: TCGA-L9-A743; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; age at index: 56; days to birth: -20780; ethnicity: not hispanic or latino; gender: male; race: black or african american; vital status: Alive; year of birth: 1957; age at diagnosis: 20780; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic stage: Stage IIA; ajcc pathologic t: T2a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 664.0; icd 10 code: C34.1; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Upper lobe, lung; synchronous malignancy: No; tissue or organ of origin: Upper lobe, lung; tumor grade: Not Reported; year of diagnosis: 2013; alcohol history: Not Reported; cigarettes per day: 2.219178082191781; pack years smoked: 40.5; is ffpe: false; composition: Not Reported; days to collection: 97; days to sample procurement: 0; initial weight: 520.0; portion submitter id: TCGA-L9-A743-01A-43; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 20.0; percent necrosis: 0.0; percent neutrophil infiltration: 20.0; percent normal cells: 0.0; percent stromal cells: 25.0; percent tumor cells: 75.0; percent tumor nuclei: 75.0;